TIDMBVC
RNS Number : 9242R
BATM Advanced Communications Ld
06 March 2023
LEI: 213800FLQUB9J289RU66
6 March 2023
BATM Advanced Communications Limited
("BATM" or the "Group")
Full Year Results
BATM (LSE: BVC; TASE: BVC), a leading provider of real-time
technologies for networking solutions and medical laboratory
systems, announces its preliminary results for the year ended 31
December 202 2 .
Financial Summary
$m 2022 2021
Results from ongoing operations (adjusted)*
Revenue 116.1 132.8
Revenue on a constant currency 125.6 -
basis**
Gross profit 38.4 50.2
Gross margin 33.0% 37.8%
----------------------------------- ----------------------- ------------------------
Operating profit 3.7 11.3
EBITDA 8.0 15.7
----------------------------------- ----------------------- ------------------------
Reported results
--------------------------------------------------------------------------------------
Revenue 116.1 140.0
----------------------- ------------------------
Gross profit 38.0 51.1
----------------------- ------------------------
Gross margin 32.7% 36.5%
----------------------------------- ----------------------- ------------------------
Operating profit 3.1 24.4
----------------------------------- ----------------------- ------------------------
EBITDA 8.0 29.6
----------------------------------- ----------------------- ------------------------
Basic earnings per share (cents) 0.06c 3.26c
----------------------------------- ----------------------- ------------------------
Cash and short-term investment
in deposits and other securities 44.2 67.8
----------------------------------- ----------------------- ------------------------
* Adjusted to present the results on an ongoing operations basis
by excluding (1) the contribution to 2021 from NGSoft, a subsidiary
that BATM sold in March 2021, and (2) the amortisation of
intangible assets for both periods. The term 'ongoing operations'
in this announcement is used for comparative purposes only and is
not used in the same context as in accounting standards. For
further information see Note 3 - Other Alternative Measures.
** Revenue from ongoing operations for 2022 based on the
currency rates prevailing in 2021. Revenue during the period was
impacted by the strengthening of the US dollar against the local
currencies primarily of subsidiaries in the Bio-Medical
division.
Operational Summary
Networking & Cyber Division (24% of total revenue)
-- Revenue from ongoing operations increased by 34.4% to $27.9m
(2021: $20.7m), reflecting strong growth in both the Networking and
Cyber units
-- Networking Unit
o Edgility edge computing and network function virtualisation
("NFV") platform:
-- Generated first revenue from Edgility, contributing to the
Networking unit's growth; total backlog for Edgility was $5.2m at
year end
-- Awarded multi-year contract from CityFibre, the UK's largest
independent carrier-neutral Full Fibre platform, for Edgility
licences plus certain hardware
-- Established two new partnerships to boost Edgility's sales
and marketing presence through the offering of joint solutions
-- Sustained engagement with several potential customers
worldwide
o Network Edge (carrier ethernet and mobile backhaul):
-- Strong increase in revenue despite ongoing impact of supply
chain challenges
-- New orders received primarily from existing customers for
BATM's latest high-capacity solutions
-- Cyber Unit
o Substantial growth in revenue from delivering on the
high-value contracts won in the previous year
o Post period, in January 2023, won a $26m multi-year government
defence order for latest high-performance cyber security
solution
Bio-Medical Division (76% of total revenue)
-- Revenue was $88. 3 m (2021: $112.0 m ); o n a constant
currency basis, revenue was $97.5m; excluding the contribution to
both years from sales of COVID-19 related products, revenue
increased to $79.9m (2021: $74.9m)
-- Diagnostics Unit
o Sales increased of molecular diagnostic products not related
to COVID-19, which was offset by market-wide reduction in prices,
as well as lower demand, for COVID-19 products as the global
pandemic subsided
o Commercially launched new multi-respiratory diagnostics
test
o Progressed development of new diagnostics tests, including in
collaboration with organisations such as Stop TB Partnership and
BIOASTER
o Opened new state-of-the-art diagnostics laboratories and
facilities in Italy and Israel to support the activity of ADOR
Diagnostics ("ADOR"), which is developing its proprietary
isothermal diagnostic solution
o ADOR received an additional $10m of investment, of which BATM
contributed $4m (giving BATM a shareholding of 37.2%)
-- Eco-Med Unit
o Completed delivery of two contracts for BATM's ISS AGRI
solution and significantly advanced two further installations
o Received EUR3.6m order for ISS-based bio-waste treatment
solutions for medical settings, with delivery commencing in Q4 2022
and due to complete during 2023
-- Distribution Unit
o Delivered greater volume of regular business and increased
sales prices, which, on a constant currency basis, enabled 6.8%
revenue growth
Commenting on the results, Moti Nagar, Chief Executive Officer
of BATM, said: "In 2022, there was robust underlying performance
across our business as the effects of the pandemic increasingly
subsided and we returned our focus to our regular activities. In
particular, we achieved a key milestone with Edgility being awarded
a contract by a major network provider in the UK, CityFibre. We
believe Edgility will be instrumental in driving our future growth
and so we are greatly encouraged by the increased interest and
visibility over sales. Accordingly, while our revenues were
negatively impacted by currency and lower demand for COVID-19
products, we exited the year as a stronger business than we were
prior to the outbreak of the pandemic.
"Looking ahead, the momentum of the second half of the year has
been sustained into 2023 and we expect increased revenue in all our
units. Having become the CEO at the start of this year, I have been
visiting and meeting our business units, reviewing our strategy and
building our plans for delivering sustainable growth. With the
solid foundations that we have in place in core technologies that
we believe will be market disrupters, t he Board remains confident
in the prospects of the business and is working hard to demonstrate
the substantial value that exists within BATM."
Enquiries:
BATM Advanced Communications
Moti Nagar, Chief Executive Officer
Ran Noy, Chief Financial Officer +972 9866 2525
Shore Capital
Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory) +44 20 7408 4050
Gracechurch Group
Harry Chathli, Claire Norbury +44 20 4582 3500
The information communicated in this announcement is inside
information for the purposes of Article 7 of Regulation
596/2014.
Forward-looking statements
This document contains forward-looking statements. Those
statements reflect the current opinions, evaluations and
estimations of the Group's management, and are based on the current
data regarding the Group's business as is detailed in this document
and in the Group's periodical, interim and immediate reports. The
Group does not undertake any obligation or make any representation
that actual results and events will be in line with those
statements, and stresses that they may differ materially from those
statements, due to changes in the Group's business, market,
competition, demand for the Group's products or services, general
economic factors or other factors that can influence the Group's
business and results, due to the risk factors that are detailed in
the Group's Annual Report, and due to information and factors that
are currently unknown to the Group's management and that, if known,
would affect the management's opinions, evaluations or estimations.
The Group will report the actual results and events according to
its legal, accounting and regulatory obligations, and does not
undertake any other obligation to report them or their deviations
from the forward-looking statements, or to update any of the
forward-looking statements in this document or to report that it is
not valid anymore.
Operational Review
BATM performed well during the year to 31 December 2022. Revenue
increased by 34.4% from ongoing operations in the Networking &
Cyber division, which offset the contribution to the previous year
from NGSoft, a subsidiary that BATM sold in 2021. BATM also gained
good traction for its Edgility edge computing and virtual
networking solution, which is now poised for rapid
commercialisation. In the Bio-Medical division, there was a
reduction in revenue, as expected, compared with the exceptional
performance in the previous year due to the pandemic. When
excluding the contribution to both years from sales of products
related to COVID-19, the Bio-Medical division revenue grew by 6.7%
- with increased sales more than offsetting the negative effect of
currency fluctuations.
Post year end, on 1 January 2023, Moti Nagar assumed the role of
Chief Executive Officer of BATM, having been Chief Financial
Officer since 2015. On 1 February 2023, Ran Noy was appointed Chief
Financial Officer of BATM, having been VP Finance since 2021.
Networking & Cyber Division
Adjusted* R eported
-------------- --------------
$m 2022 2021 2022 2021
------ ------
Revenue 27.9 20.7 27.9 28.0
Gross margin 44.7% 45.0% 43.9% 36.9%
------------------------- ------ ------ ------ ------
Operating (loss)/profit (0.9) (5.6) (1.2) 7.8
* Adjusted to present the results an ongoing operations basis by
excluding (1) the contribution to 2021 from NGSoft, a subsidiary
that BATM sold in March 2021, and (2) the amortisation of
intangible assets for both periods.
Revenue in the Networking & Cyber division increased by
34.4% on an ongoing operations basis (excluding the contribution to
2021 from NGSoft), reflecting robust growth in both the Networking
and the Cyber units. As a result of this strong underlying
performance, BATM achieved revenue on a reported basis in line with
the previous year despite the sale of NGSoft.
Gross margin improved in the Networking and Cyber units
respectively. On a blended basis, the division's gross margin for
ongoing operations was 44.7% compared with 45.0%, which reflects
the change in the division's revenue mix based on the relative
contribution from the Networking and Cyber unit respectively. On a
reported basis, gross margin increased substantially due to the
lower margin nature of the NGSoft business included in the previous
year.
Operating loss from ongoing operations was reduced to $0.9m
(2021: $5.6m loss) thanks to the higher revenue and gross profit as
well as the contribution from the sale of a property as described
in the Financial Review below. On a reported basis, the operating
loss was $1.2m compared with an operating profit of $7.8m for 2021
as a result of the exceptional capital gain of $13.0m from the sale
of NGSoft in the prior year.
Networking
In the Networking unit, revenue on an ongoing operations basis
(excluding the contribution to 2021 from NGSoft) increased by
20.5%. This reflects higher sales of BATM's network edge solutions
and services and a material contribution to growth from Edgility
.
Edgility - Edge Computing and NFV solutions
BATM achieved a significant milestone during the year with the
signing of a multi-year contract with CityFibre, the UK's largest
independent carrier-neutral Full Fibre platform, for the deployment
of its Edgility virtual networking and edge compute solution, which
followed an extensive testing and piloting phase. This is part of
CityFibre's programme to replace its hardware-based customer
premise routing equipment with a virtualised solution based on
small-footprint white-box appliances (a multi-purpose device)
operated by Edgility. For this initial order, BATM will receive
recurring licence fees for a five-year period plus certain hardware
sales estimated to be worth a total of $3.5m. BATM expects this
order to be followed by a substantial expansion in deployments as
CityFibre rolls out Edgility to its full network.
BATM also commenced executing, and received its first revenue,
on two contracts for Edgility, which are expected to have an
aggregate value of $2.7m over a five-year period, that were awarded
at the end of 2021. This includes the first enterprise customer for
Edgility, CEMEX, S.A.B, (NYSE: CX), which is a global construction
materials company, and e-Qual, a global Managed Services Provider
based in France that operates in 55 countries.
Edgility continued to undergo evaluation with leading network
operators, multi-service providers and systems integrators
worldwide, including CityFibre as noted above . Edgility is fast
being recognised internationally as a breakthrough solution and has
won several industry awards. Consequently, the interest in Edgility
has seen a significant increase and BATM is in advanced discussions
with several potential customers having undertaken further
proof-of-concepts in Q4 2022 and in the current year. As at year
end, the total backlog for Edgility was $5.2m.
To expand the sales and marketing reach, and provide further
routes to market, BATM continued to establish strategic
partnerships, which primarily involve Edgility being pre-integrated
with, or pre-installed on, the partner's network appliances (with
customers that use the Edgility solution contracting with BATM
directly). During the year, this includes establishing partnerships
with:
-- Advantech (TWSE: 2395), a global leader in industrial IoT,
which is providing Edgility pre-installed on a variety of its
universal edge network appliances.
-- NEXCOM International Co Ltd (TPEX: 8234), a leading supplier
of network appliances, which offers Edgility pre-installed on its
5G-ready device designed for the small-office-home-office and
mid-range enterprise market.
Network Edge solutions and services
Revenue from network edge solutions and services, where BATM
provides carrier ethernet and mobile backhaul platforms, grew
significantly driven by sales price and volume increases, despite
the ongoing impact of global electronic components shortages
causing delays to the delivery of some orders. This growth was
primarily based on orders from existing customers for BATM's new
100GE devices, such as the TM-8104 carrier ethernet aggregation
solution, as well as from the fulfilment in 2022 of carrier
ethernet sales secured in 2021. In addition, BATM launched a new
multipurpose, ultra-high-capacity demarcation platform, the
TM-8106, and has received initial strong interest.
Cyber
The Cyber unit performed strongly with revenue increasing by
73.1% year-on-year, primarily reflecting the execution of contracts
awarded in 2021 and with a backlog still to be delivered in 2023.
This was significantly increased, post period, with the award in
January 2023 of a $26m order from BATM's long-standing defence
department customer to be delivered over a period of a maximum of
five years. BATM continues to expect to receive more orders from
this customer within this period.
The Cyber unit also continued its development efforts. This
included advancing its previous generation of product to increase
performance and throughput - resulting in the $26m order in January
2023 - as well as continuing the development of a version of its
cyber security solution aimed beyond the defence industry,
including for the corporate market, which will significantly expand
the addressable market.
Bio-Medical Division
Adjusted* Reported
-------------------- --------------
$m 2022 2021 2022 2021
------ ------------
Revenue 88. 3 112.0 88. 3 112.0
Revenue on a constant currency 97.5 - - -
basis**
-------------------------------- ------ ------------ ------ ------
Gross margin 29.4% 36.5% 29.2% 36.4%
-------------------------------- ------ ------------ ------ ------
Operating profit 4.6 17.0 4.3 16.5
* Adjusted to exclude the amortisation of intangible assets.
** Revenue for 2022 based on the currency rates prevailing in
2021.
Revenue for the Bio-Medical division was $88. 3 m (2021:
$112.0m). On a constant currency basis, excluding the impact of the
strengthening of the US dollar against local currencies, revenue
was $97.5m. Revenue in the division was negatively impacted by the
decline in market demand for COVID-19 products; excluding the
contribution to both years from COVID-19 related products, revenue
increased by 6.7% from $74.9m in 2021 to $79.9m in 2022.
Adjusted gross margin for the division was 29.4% (2021: 36.5%),
primarily reflecting the contribution to revenue in 2021 of the
higher-margin COVID-19 products. Excluding COVID-19 related
products, gross margin in the Bio-Medical division increased from
25.4% in 2021 to 27.6% in 2022. The Bio-Medical division generated
an adjusted operating profit of $ 4.6m for 2022 compared with $
17.0m for the previous year.
Diagnostics
Revenue in the Diagnostics unit accounted for 12.8% of the
Bio-Medical division compared with 28.2% in 2021. There was an
increase in revenue from BATM's range of molecular diagnostic
products that are not related to COVID-19, which were sold to
customers in Europe and the Middle East. However, this increase was
more than offset by lower demand, as well as a market-wide
reduction in prices, for COVID-19 products as the global pandemic
subsided, alongside a negative impact of the strengthening of the
US dollar against local currencies.
This year BATM continued with its programme to enhance its
diagnostic operations. At its Adaltis subsidiary, this included
steps to optimise the production process. BATM opened a new
state-of-the-art laboratory in Israel, which is focused on research
& development, and new product assembly rooms in Rome, Italy,
to support the activity of BATM's ADOR associate company, which is
developing the NATlab molecular biology solution .
BATM also continued to progress its development work. This
includes its new molecular diagnostics test for multiple
respiratory pathogens receiving CE certification and being
commercially launched towards the end of the year. BATM is
continuing to develop new kits, such as for sepsis, as well as
collaborating on projects such as to develop a new test for the
diagnosis of tuberculosis as part of its work with the Stop TB
partnership.
ADOR established the development of its novel isothermal rolling
circle amplification ("RCA") method for multiplex pathogens
detection. In parallel, work continued on incorporating it into the
NATlab system. The respiratory panel is planned to be the first
commercial application of this technology. In addition, ADOR has
initiated a new test for the diagnosis of sexually transmitted
infections in cooperation with BIOASTER, the French Microbiology
Technology Research Institute.
During the year, BATM and its partners invested an additional
$10m into ADOR, of which the Group contributed $4m (giving BATM a
shareholding of 37.2%). The additional investment contributed to
the opening of the new laboratory and will be used to prepare ADOR
for the pre-production stage, register additional patents (mainly
in the US), progress development of more disease panels and
certifications and increase the cooperation with international
bodies, including the World Health Organisation.
Eco-Med
The Eco-Med unit accounted for 7.6% of the Bio-Medical
division's revenues in 2022 compared with 7.7% in 2021.
There was good progress in deliveries of BATM's solution, the
ISS AGRI, for the treatment of pathogenic waste in agricultural and
pharmaceutical settings. This was primarily under contracts that
had previously been secured, but where completion had been delayed
due to pandemic-related restrictions. BATM completed the delivery
of two of its ISS AGRI contracts and advanced the delivery of two
further contracts. The delivery of the latter two contracts was
impacted by supply chain disruption - with one of the solutions now
undergoing final engineering ahead of completion and the solution
under the other contract is soon to be installed.
BATM also received a EUR3.6m order for its ISS-based bio-waste
treatment solutions for medical settings, with delivery commencing
in Q4 2022 and due to complete in 2023. The order was from a new
customer, a hospital, and BATM expects to receive a follow-on order
in due course.
Distribution
Revenue in the Distribution unit accounted for approximately
79.7% of the Bio-Medical division's revenue (2021: 64.1%). On a
reported basis, revenue was broadly in line with the previous year
due to the negative currency impacts, however underlying sales,
excluding currency impact, increased by 6.8%. This underlying
growth was based on a greater volume of regular business as well as
an increase in sales prices and was achieved despite a decline in
COVID-19 related sales . Excluding the contribution to both years
of sales of COVID-19 related products, revenue in the Distribution
unit increased by 10.3%, with greater sales more than offsetting
the currency impact. Towards the end of the year, BATM gained
control of one of its associated companies.
Financial Review
Adjusted* Reported
----------------- -------------------
$m 2022 2021 2022 2021
------- --------
Revenue 116.1 132.8 116.1 140.0
Revenue on a constant currency
basis** 125.6 132.8 - -
-------------------------------- ------- -------- ---- ------- -------
Gross margin 33.0 % 37.8% 32.7 % 36.5 %
-------------------------------- ------- -------- ---- ------- -------
Operating profit 3.7 11.3 3.1 24.4
* Adjusted to present the results an ongoing operations basis by
excluding (1) the contribution to 2021 from NGSoft, a subsidiary
that BATM sold in March 2021, and (2) the amortisation of
intangible assets for both periods.
** Revenue from ongoing operations for 2022 based on the
currency rates prevailing in 2021.
Total Group revenue for the year was $116.1m (2021: $132.8m for
ongoing operations, which excludes the contribution from NGSoft, a
subsidiary that BATM sold in March 2021), with growth in the
Networking & Cyber division being offset by a reduction in the
Bio-Medical division, primarily reflecting lower sales of COVID-19
products as well as the impact of the strengthening of the US
dollar. On a constant currency basis, revenue for the year was
$125.6m. Excluding the contribution to both years of COVID-19
related sales, the revenue for ongoing operations increased by
12.7% to $107.8m (2021: $95.6m), more than offsetting the negative
currency impact.
Gross margin for the year was 33.0% compared with 37.8% for
ongoing operations for the previous year. This reflects the
contribution to FY 2021 revenue of the high-margin COVID-19
products. Excluding the contribution of COVID-19 related products
to both years, BATM's gross margin for ongoing operations improved
to 32.0% (2021: 29.7%) as increased sales prices offset the
negative impact of currencies and inflation.
Sales and marketing expenses were $17.2m (2021: $18.1m for
ongoing operations; $18.3m on a reported basis to include NGSoft),
representing 14.8% of revenue compared with 13.7% for ongoing
operations in 2021. The decrease in expenses reflects the costs
associated with COVID-19 product sales in 2021, with the reduction
being partly offset by price inflation.
General and administrative expenses were $13.0m ( 2021: $11.9m
for ongoing operations; $12.2m on a reported basis), representing
11.2% of revenue (2021: 9.0% for ongoing operations). R&D
expenses were $7.0m (2021: $8.6m for ongoing operations; $8.7m on a
reported basis).
Other operating income was $2.4m, which was from the disposal of
one of BATM's properties in the US - generating a profit for BATM
of $2.1m. This compares with other operating income in the previous
year of $12.6m, which was mainly attributed to the profit from the
sale of NGSoft.
Adjusted operating profit was $3.7m (2021: $11.3m), with the
reduction primarily due to the lower revenue from COVID-19
products. On a reported basis, operating profit (which includes
amortisation and, for 2021, the contribution from NGSoft) was $3.1m
compared with $24.4m for 2021, with the prior year including a
capital gain of $13.0m from the sale of NGSoft.
As a result of the above, EBITDA for 2022 was $8.0m compared
with $15.7m for 2021 for ongoing operations and $29.6m on a
reported basis.
Net finance expense was $1.2m (2021: $0.6m net finance income).
The higher financial expenses were mainly due to the impact on
balance sheet positions of the strengthening of the US dollar
compared with 2021.
BATM recorded a $0.3m tax expense (2021: $9.3m tax expense). The
tax decrease is a result of an approximately $1m non-cash tax
incentive and lower profit before tax while 2021 included a
non-recurring tax expense related to the NGSoft transaction.
Net profit after tax attributable to equity holders of the
parent was $0.2m (2021: $14.3m ) resulting in basic earnings per
share of 0.06c (2021: 3.26c).
As at 31 December 2022, inventory wa s $34.5m (31 December 2021:
$31.0m). Trade and other receivables were $36.5m (31 December 2021:
$34.9m) .
Intangible assets and goodwill at 31 December 2022 were $ 18.5 m
(31 December 2021: $16.0m).
Property, plant and equipment and investment property was $15.9m
(31 December 2021: $19.8m), with the reduction primarily due to the
disposal of one of BATM's properties.
The balance of trade and other payables was $46.3m (31 December
2021: $47.5m).
Cash used in operations (before interest and tax payments) was
$1.1m compared with cash from operations of $8.7m in 2021 due to
the higher profit in the prior year because of COVID-19 related
sales .
At 31 December 2022, BATM had cash and cash equivalents and
short-term investment in deposits and other securities of $44.2m
(31 December 2021: $67.8 m ). Short-term investment in deposits and
other securities represent cash deposits of more than three months'
duration, held for trading bonds and marketable securities. The
change in cash and cash equivalents and short-term investment in
deposits and other securities compared with the prior year
primarily reflects dividend payment of $4.3m; buy-back payments of
$1.3m; an additional investment in ADOR of $4m; tax payments
relating to the NGSoft transaction; and the impact of the weakening
of the currencies in which BATM's subsidiaries operate compared
with the US dollar .
Capital Allocation
BATM 's primary use of capital is investment in research and
development and its go-to-market strategy, capital expenditure and
for working capital. The Board also considers returns to
shareholders to be an important element of its strategy to deliver
shareholder value as demonstrated during the year by distributing a
dividend totalling $4.3m (declared in December 2021) and executing
a buyback of 4,495,000 ordinary shares for a total of $1.3m.
Outlook
BATM entered 2023 with strong momentum across the business and a
solid backlog to be delivered during the year. Accordingly, BATM
expects to report strong growth for 2023, reflecting a double-digit
percentage increase in revenue in all units.
In particular, in the N etworking & C yber division , BATM
expects the main contributor to growth to be from sales of Edgility
- including new customers and expansion with existing customers .
In the Cyber unit, BATM is on track for strong growth based on
delivery of its backlog of orders received prior to 2023 and the
commencement of delivery of the $26m order awarded in January of
this year. As noted, BATM also expects to receive further orders in
its Cyber unit during the year. In addition, the strong revenue
growth in the Networking & Cyber division is expected to enable
the division to generate an operating profit for full year
2023.
In the Bio-Medical division, BATM expects significant growth of
sales of its diagnostic products in 2023. BATM is not including in
its forecasts the $25m tender, as noted in its trading update
announcement of 8 December 2022, for COVID-19 testing kits from a
potential customer in Southeast Asia. However, the strong growth
anticipated of BATM's diagnostic products not related to COVID-19
is expected to deliver a year-on-year increase in the Diagnostic
unit's revenue. BATM continues to expect increased revenue in the
Distribution and Eco-Med units.
Since becoming CEO on 1 January 2023, Moti Nagar has commenced a
detailed process of assessing BATM's strategy and preparing a plan
to accelerate BATM's sustainable growth. BATM will update the
market on the outcome of this undertaking in due course.
BATM has established solid foundations in core technologies that
it believes will be market disrupters. The Group is profitable with
a very strong balance sheet comprising both cash and short-term
investment in deposits and other securities of $ 44.2 m as at year
end as well as property and valuable IP. In addition, BATM's total
current backlog is significantly higher than at the same point last
year. Accordingly, the Board of BATM remains confident in the
prospects for the business and continues to explore all options to
deliver shareholder value.
BATM ADVANCED COMMUNICATIONS LTD.
CONSOLIDATED STATEMENTS OF PROFIT OR LOSS
Year ended
31 December
2022 2021
US$ in thousands
Unaudited Audited
Revenues 116,123 140,038
Cost of revenues 78,165 88,977
Gross profit 37,958 51,061
--------- ---------
Operating expenses
Sales and marketing expenses 17 ,2 09 18,290
General and administrative expenses 1 3 , 018 12,243
Research and development expenses 7,025 8,713
(2, 428
Other operating income ) (12,563)
Total operating expenses 34,824 26,683
--------- ---------
Operating profit 3,134 24,378
Finance income 772 1,466
( 2,011
Finance expenses ) (911)
Profit before tax 1,895 24,933
Income tax expenses ( 339 ) (9,337)
Profit for the year before share of loss of a
joint venture
and associated companies 1 ,5 5 6 15,596
Share of loss of a joint venture and associated
companies ( 686 ) (839)
Profit for the year 870 14,757
Attributable to:
Owners of the Company 244 14,340
Non-controlling interests 626 417
Profit for the year 870 14,757
Earnings per share (in cents):
Basic 0.06 3.26
Diluted 0.06 3.23
BATM ADVANCED COMMUNICATIONS LTD.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Year ended 31 December
2022 2021
Unaudited Audited
US$ in thousands
Profit for the year 870 14,757
Items that may be reclassified subsequently
to profit or loss:
Disposal of a foreign operation - (522)
( 5,810
Exchange differences on translating foreign operations ) (4,880)
(5,810) (5,402)
Items that will not be reclassified subsequently
to profit or loss:
Re-measurement of defined benefit obligation 65 162
65 162
Total other comprehensive loss for the year (5,745) (5,240)
Total comprehensive income (loss) for the year (4,875) 9,517
Attributable to:
Owners of the Company (5,727) 8,976
Non-controlling interests 852 541
(4,875) 9,517
BATM ADVANCED COMMUNICATIONS LTD.
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
31 December
2022 2021
US$ in thousands
Unaudited Audited
Current assets
Cash and cash equivalents 35,156 65,331
Trade and other receivables 36,495 34,932
Short-term investment in deposits and other
securities 9,011 2,432
Inventories 34,461 30,951
115,123 133,646
Non-current assets
Property, plant and equipment 15,309 1 8,107
Investment property 620 1 ,739
Right of-use assets 5,461 6,570
Goodwill 12,583 11,385
Other intangible assets 5,948 4,648
Investment in joint venture and associate 15,555 12,667
Investments carried at fair value 1,220 1,027
Deferred tax assets 3,362 3,375
60,058 59,518
Total assets 175,181 193,164
Current liabilities
Short-term bank credit 2,235 1,634
Trade and other payables 46,256 47,519
Current maturities of lease liabilities 1,984 2,186
Tax liabilities 818 6,548
51,293 57,887
Non-current liabilities
Long-term bank credit 2,000 1,356
Long-term liabilities 3,472 3,888
Long-term lease liabilities 3,758 5,108
Deferred tax liabilities 120 170
Retirement benefit obligation 537 621
9,887 11,143
Total liabilities 61,180 69,030
Equity
Share capital 1,320 1,320
Share premium account 426,138 425,840
Reserves (32,812) (19,849)
Accumulated deficit (279,579) (279,888)
Equity attributable to the:
Owners of the Company 115,067 127,423
Non-controlling interests (1,066) (3,289)
Total equity 114,001 124,134
Total equity and liabilities 175,181 193,164
BATM ADVANCED COMMUNICATIONS LTD.
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
Year ended 31 December 202 2 (U na udited)
Share Attributable Non-Controlling
Share Premium Translation Other Accumulated to Owners Interests Total
Capital Account Reserve Reserve Deficit of the Equity
Company
US$ in thousands
Balance as
at 1 January 127,42 124,13
2022 1,320 425,840 (19,337) (512) (279,888) 3 (3,289) 4
Profit for
the year - - - - 244 244 626 870
Other
comprehensive
income (loss)
Re-measurement
of defined
benefit
obligation - - - - 65 65 - 65
Exchange
differences
on translating
foreign
operations - - (6,036) - - (6,036) 226 (5,810)
Other
comprehensive
income (loss)
for the year - - (6,036) - 65 (5,971) 226 (5,745)
Total
comprehensive
income (loss)
for the year - - (6,036) - 309 (5,727) 852 (4,875)
Dividend paid
to
non-controlling
interest - - - - - - (681) (681)
Share buy-back - - - (1,325) - (1,325) - (1,325)
Recognition
of share-based
payments - 298 - - - 298 - 298
Transaction
with non-
controlling
interests - - (666) (4,936) - (5,602) 2,052 (3,550)
Balance as
at 31 December
2022 1,320 426,138 (26,039) (6,773) (279,579) 115,067 (1,066) 114,001
BATM ADVANCED COMMUNICATIONS LTD.
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
Year ended 31 December 202 1 (Audited)
Share Attributable Non-Controlling
Share Premium Translation Other Accumulated to Owners Interests Total
Capital Account Reserve Reserve Deficit of the Equity
Company
US$ in thousands
Balance as
at 1 January
2021 1,320 425,686 (13,811) (512) (290,090) 122,593 (3,830) 118,763
Profit for
the year - - - - 14,340 14,340 417 14,757
Disposal of
a foreign
operation - - (522) - - (522) - (522)
Re-measurement
of defined
benefit
obligation - - - - 162 162 - 162
Exchange
differences
on translating
foreign
operations - - (5,004) - - (5,004) 124 (4,880)
Total
comprehensive
income for
the year - - (5,526) - 14,502 8,976 541 9,517
Exercise of
share-based
options by
employees (*) 58 - - - 58 - 58
Recognition
of share-based
payments - 96 - - - 96 - 96
Dividends - - - - (4,300) (4,300) - (4,300)
Balance as
at 31 December 127,42 124,13
2021 1,320 425,840 (19,337) (512) (279,888) 3 (3,289) 4
(*) Less than 1K USD
BATM ADVANCED COMMUNICATIONS LTD.
CONSOLIDATED STATEMENT OF CASH FLOW
Year ended 31 December
2022 2021
Unaudited Audited
US$ in thousands
Net cash from (used in) operating activities
(Appendix A) (2,784) 5,592
Investing activities
Purchases of property, plant and equipment (2, 414 ) (2,889)
Increase of other intangible assets ( 2,054 ) (400)
Investment in joint venture and associated
companies ( 4,386 ) (727)
Proceeds on disposal of property, plant and
equipment 4,514 18
Investment in a subsidiary (550) -
Proceeds from sale of a subsidiary (Appendix
C) - 18,662
Tax payment related to disposal of a subsidiary (4,953) -
Proceeds on disposal of deposits and securities 4,941 717
Purchases of deposits and financial assets (11,733) ( 31 5)
Other (Appendix B) 293 3
Net cash from (used in) investing activities (16,342) 15,069
Financing activities
Lease payment (2,1 92 ) (2,174)
Bank loan repayment (1 1 , 017 ) (13,252)
Bank loan received 12,465 10,431
Dividend paid (4,300) -
Dividend paid to NCI (681) -
Share buy-back (1,325) -
Proceed on exercise of share-based payments - ___58
Net cash used in financing activities (7,050) (4,937)
Net increase (decrease) in cash and cash
equivalents ( 26,176 ) 15,724
Cash and cash equivalents at the beginning
of the year 65,331 50,575
Effects of exchange rate changes on the balance
of cash held in foreign currencies (3,999) (968)
Cash and cash equivalents at the end of
the year 35,156 65,331
BATM ADVANCED COMMUNICATIONS LTD.
APPICES TO CONSOLIDATED STATEMENT OF CASH FLOW
APPIX A
RECONCILIATION OF OPERATING PROFIT FOR THE YEAR TO NET CASH FROM
(USED IN) OPERATING ACTIVITIES
Year ended 31 December
2022 2021
Unaudited Audited
$'000 $'000
Operating profit from operations
Adjustments for: 3,134 24,378
Amortisation of intangible assets 557 716
Depreciation of property, plant and equipment and
investment property 4,334 4,548
Capital gain of property, plant and equipment (2,021) (229)
Profit from sale of a subsidiary - (13,035)
Gain from revaluation of investment carried at fair (192) -
value
Gain from business combination achieved in stages (404) -
over an associated company
Share based payments 298 96
Increase (decrease) in retirement benefit obligation 23 (10)
Increase (decrease) in provisions 105 (1,803)
Operating cash flow before movements in working
capital 5,834 14,661
Decrease (increase) in inventory (3,258) 3,031
Increase in receivables (803) (2,052)
Decrease in payables (1,291) (5,352)
Effects of exchange rate changes on the balance
sheet (1,556) (1,616)
Cash from (used in) operations (1,074) 8,672
Income taxes paid (985) (2,383)
Interest paid (725) (697)
Net cash from (used in) operating activities (2,784) 5,592
BATM ADVANCED COMMUNICATIONS LTD.
APPICES TO CONSOLIDATED STATEMENT OF CASH FLOW
APPIX B
BUSINESS COMBINATION ACHIEVED IN STAGES OVER AN ASSOCIATED
COMPANY
Towards the end of the year, the Group gained control of one of
its associated companies for an immaterial amount.
Year ended
31 December
202 2
$'000
Unaudited
Net assets acquired
Current assets 523
Cash 29
Property, plant and equipment 22
Current Liabilities (514)
60
Goodwill 1,429
Total consideration 1,489
Satisfied by:
Disposal of investment in associated 775
Liability of acquisition 714
1,489
Net cash inflow arising on business combination:
Cash and cash equivalents acquired 29
BATM ADVANCED COMMUNICATIONS LTD.
APPICES TO CONSOLIDATED STATEMENT OF CASH FLOW
APPIX C
DISPOSAL OF SUBSIDIARY - NGSoft
On 19 March 2021, the Group entered into a sale agreement to
dispose of NG Soft Ltd. ("NGSoft ( to Aztek Technologies (1984)
Ltd., a provider of ICT cloud services in Israel and a portfolio
company of SKY Fund. NGSoft is a software and digital services
company that provides creative digital and technology solutions
.
Year ended
31 December
2021
$'000
Audited
Net assets disposed
Property, plant and equipment 1,144
Right of use 3,667
Other intangible assets 968
Net working capital 73
Lease liability (3,764)
Current tax liability (584)
Deferred tax liability (540)
Goodwill 5,185
Net assets disposed of 6,149
Disposal of a foreign operation (522)
Gain on disposal 13,035
Total consideration 18,662
Net cash inflow arising on disposal:
Consideration received in cash and cash equivalents, net 20,903
Cash and cash equivalents disposed (2,241)
18,662
BATM ADVANCED COMMUNICATIONS LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Note 1 - General
The final results, together with the relevant notes, for the
year ended 31 December 2022 and the comparative 2021 information
will be presented in the full Annual Report in accordance with
International Financial Reporting Standards ("IFRS").
Note 2 - Earnings per share
Earnings per share is based on the weighted average number of
shares in issue for the period of 440,167,097 (2021: 440, 437 , 960
) including 4,495,000 ordinary shares held in treasury. The number
used for the calculation of the diluted earnings per share for the
period (which includes the effect of dilutive stock option plans)
is 44 2 , 357 , 116 shares (2021: 444,267,674).
Note 3 - Other alternative measures
1. Income statement adjustments - including (1) the contribution
to 2021 from NGSoft, a subsidiary that the Group sold in March
2021, and (2) adjustments related to the amortisation of intangible
assets.
Year ended 31 December 2022 Reported Amortisation Adjusted
(Unaudited ( results of intangible results (ongoing
assets operations)
US$ thousands
Gross profit 37,958 (414) 38,372
Gross margin (%) 3 2.7 % - 33.0 %
Other operating expenses ( 2,428
(income) ) 143 (2,571)
Operating profit 3,134 ( 557 ) 3,691
Year ended 31 December Reported Adjustments Amortisation Adjusted
202 1 (Unaudited ( results to exclude of intangible results (ongoing
NGSoft assets operations)
US$ thousands
Revenues 140,038 7,262 - 132,776
Gross profit 51,061 1,235 (414) 50,240
Gross margin (%) 36.5% 17.0% - 37.8%
Sales and marketing
expenses 18,290 144 - 18,146
General and
administrative
expenses 12,243 358 - 11,885
Research and development
expenses 8,713 - 106 8,607
Other operating expenses
(income) (12,563) (12,994) 154 277
Operating profit 24,378 13,727 (674) 11,325
EBITDA 29,642 13,956 - 15,686
2. EBITDA measurement
Reported Adjusted
Year ended 31 December Year ended 31 December
US$ in thousands 2022 2021 2022 2021
------------ ------------
(Unaudited) (Unaudited) (Unaudited) (Unaudited)
Operating profit 3,134 24,378 3,691 11,325
Amortisation of Intangible
assets 557 7 16 - -
Depreciation 4, 334 4, 458 4, 334 4, 361
EBITDA 8,025 29,642 8,025 15,686
Note 4 - Segments
Business Segment
Year ended 31 December 2022 (Unaudited)
Networking Bio-Medical Total
and Cyber $'000 $'000
$'000
Revenues 27,864 88,259 116,123
Operating profit/(loss) (1,152) 4,286 3,134
Net finance expenses (1,239)
Profit before tax 1,895
Year ended 31 December 2021 (Audited)
Networking Bio-Medical Total
and Cyber $'000 $'000
$'000
Revenues 27,992 112,046 140,038
Operating profit 7,844 16,534 24,378
Net finance income 555
Profit before tax 24,933
, the news service of the London Stock Exchange. RNS is approved by
the Financial Conduct Authority to act as a Primary Information
Provider in the United Kingdom. Terms and conditions relating to
the use and distribution of this information may apply. For further
information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCQELFBXXLXBBQ
(END) Dow Jones Newswires
March 06, 2023 02:00 ET (07:00 GMT)
BATM Advanced Communicat... (AQSE:BVC.GB)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
BATM Advanced Communicat... (AQSE:BVC.GB)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024
